Skip to main content
. 2020 Jun 5;4(2):rkaa020. doi: 10.1093/rap/rkaa020

Fig. 1.

Fig. 1

Cumulative incidence of persistent transaminitis during MTX treatment for RA

Using the CIF, the cumulative incidence of persistent transaminitis occurring in RA patients who initially started MTX treatment is shown. Numbers below these figures represent the number of patients remaining on MTX treatment. CIF: cumulative incidence function; IR: incidence rate; PYs: person-years